Hire App Developer for Biotech Startups
Senior, direct, no layers

The scarcest resource at a biotech startup is focused scientific time. Every hour a scientist spends reformatting data, chasing a CRO, or rebuilding an investor update is an hour not spent on the science the company exists to do. The recurring friction is experimental data scattered across notebooks and drives, CRO results arriving late or in unusable formats, and investor updates rebuilt from scratch every month.

An app developer builds the application that puts the organization's core workflow where people already are: on their phone. For biotech startups, that means the parts of assay development and validation that benefit from being portable, instant, and available outside the office.

Picture a CRO dataset arriving in a format nobody can use, days before an investor update is due. In that situation, an app that surfaces the urgent items, captures the update in seconds, and syncs it back to an electronic lab notebook such as Benchling would keep the work moving instead of waiting for someone to return to a desk. Book a free discovery call and we will test the fit on one real workflow before any wider scope is agreed.

The stack here is an electronic lab notebook such as Benchling, a LIMS, bioinformatics pipelines, and CRO data portals. The gap is usually connection, not tools: work lands in one system, records live in another, and nobody has one view of where a case stands. This engagement connects that stack and standardises the routines around it.

The app reads and writes an electronic lab notebook such as Benchling through its interfaces, with a LIMS alongside where the workflow needs it. Data stays in the organization's systems; the app is a window into them, not a separate database to reconcile later.

This page describes services, not scientific or regulatory advice. Research and regulatory decisions stay with the startup's qualified scientific staff. FDA IND and BLA pathways shapes what can be automated or changed, and the work is scoped to fit it rather than work around it.

The realistic outcome is data the team can actually use: experiments findable, CRO results comparable, and updates assembled from real results instead of rebuilt each time.

Two problems deserve naming: experimental data scattered across notebooks and drives and CRO results arriving late or in unusable formats. Both persist when the underlying routine stays manual and nobody owns the follow-up, so each deliverable in this engagement is paired with a named owner and a visible queue, and problems surface while they are still small.

What changes is timing: updates happen when the work happens, reminders land when they matter, and the record is current without a nightly catch-up.

Browse all hire engagements or discuss your biotech startup workflow directly.